3[1]James L. Januzzi Jr, et al. Fundamental Concepts in the Pathobiology of Heparin-induced Thrombocytopenia[J]. Journal of Thrombosis and Thrombolysis,2000;S7-11.
4[2]Jeanine M. Walenga, et al. Mechanisms of Venous and Arterial Thrombosis in Heparin-induced Thrombocytopenia[J]. Journal of Thrombosis and Thrombolysis,2000;S13-20.
5[3]Frederick A. Spencer, et al. Heparin-induced Thrombocytopenia:Patient Profiles and Clinical Manifestations[J]. Journal of Thrombosis and Thrombolysis,2000;S21-25.
6[4]Omar Ali. Images in Heparin-induced Thrombocytopenia[J]. Journal of Thrombosis and Thrombolysis,2000;S27-33.
7[5]Theodore E. Warkentin. Laboratory Testing for Pathobiology of Heparin-induced Thrombocytopenia[J]. Journal of Thrombosis and Thrombolysis,2000;S35-45.
8[6]Norbert Lubenow, et al.Management of Patient With Pathobiology of Heparin-induced Thrombocytopenia:Focus On Recombinant Hirudin[J]. Journal of Thrombosis and Thrombolysis,2000;S47-57.
9[7]Yves Gruel. Antiphospholipid Syndrome and Heparin-induced Thrombocytopenia: Update On Similarities and differences[J]. Journal of Autoimmunity,2000; 15:265-8.
10[8]P. A. Arndt, et al. Post-transfusion Purpura vs. Heparin-induced Thrombocytopenia: Differential Diagnosis in Clinical Practice[J]. Transfusion Medicine,2000;10:323-5.
